09:10 AM EST, 11/03/2025 (MT Newswires) -- Iradimed ( IRMD ) reported Q3 non-GAAP earnings Monday of $0.47 per diluted share, up from $0.43 a year earlier.

Two analysts polled by FactSet expected $0.46.

Revenue for the quarter ended Sept. 30 was $21.2 million, compared with $18.3 million a year earlier.

Two analysts surveyed by FactSet expected $20.5 million.

The company said it expects Q4 non-GAAP earnings of $0.47 to $0.51 per diluted share on revenue of $21.4 million to $22.4 million. Two analysts polled by FactSet expect non-GAAP earnings of $0.47 per diluted share on revenue of $20.7 million.

For 2025, Iradimed ( IRMD ) said it now expects non-GAAP earnings of $1.84 to $1.88 per diluted share, on revenue of $82.5 million to $83.5 million, up from previous guidance of non-GAAP earnings of $1.76 to $1.86 per diluted share on revenue of $80 million to $82.5 million. Two analysts polled by FactSet expect non-GAAP earnings $1.82 per diluted share on revenue of $81.1 million.

Shares of the company were up 0.5% in recent Monday premarket activity.